Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

DermTech, Inc. - Common Stock (NQ:DMTK)

0.0940 UNCHANGED
Last Price Updated: 4:00 PM EDT, Jun 26, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about DermTech, Inc. - Common Stock

< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
DermTech Appoints Mark Aguillard as Chief Commercial Officer
From DermTech, Inc.
Via Business Wire
DermTech, Inc. (NASDAQ:DMTK) Investor Notice: Investigation over Potential Wrongdoing
San Diego, CA -- (SBWIRE) -- 08/29/2023 -- Certain directors of DermTech, Inc. are under investigation over potential breaches of fiduciary duties. 
Via SBWire
DermTech Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From DermTech, Inc.
Via Business Wire
DermTech Reports Second-Quarter 2023 Financial Results
From DermTech, Inc.
Via Business Wire
Why DermTech Shares Are Rising Today
DermTech Inc (NASDAQ: DMTK) shares are trading higher Thursday after the company announced a restructuring plan. 
Via Benzinga
DermTech Earnings Perspective: Return On Capital Employed
Via Benzinga
Recap: DermTech Q1 Earnings
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
DermTech Announces Favorable Coverage Policy With Blues Plan in Michigan for the Foundational Assay of Its DermTech Melanoma Test (DMT)
From DermTech, Inc.
Via Business Wire
DermTech Announces Release Date for Second-Quarter 2023 Financial Results
From DermTech, Inc.
Via Business Wire
DermTech Adds Approximately 7 Million Covered Lives for the Foundational Assay of Its DermTech Melanoma Test (DMT)
From DermTech, Inc.
Via Business Wire
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
DermTech Announces Restructuring to Prioritize Growth Opportunities and Streamline Operations
From DermTech, Inc.
Via Business Wire
If You Own These 3 Growth Stocks, You Might Want to Rethink Your Position
All three healthcare stocks have soared this year, but their share prices may not be sustainable. 
Via The Motley Fool
ECRI Completes Evaluation of the Pigmented Lesion Assay (PLA), the Foundational Assay for the DermTech Melanoma Test (DMT)
From DermTech, Inc.
Via Business Wire
DermTech Announces Contract With Hawaii Blues Plan for the Foundational Assay of Its DermTech Melanoma Test (DMT)
From DermTech, Inc.
Via Business Wire
DermTech Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
From DermTech, Inc.
Via Business Wire
DermTech Surpasses 200,000 Cumulative Billable Samples for the DermTech Melanoma Test (DMT)
From DermTech, Inc.
Via Business Wire
DermTech Announces Agreements With South Carolina Blues Plan and the United Mine Workers of America Health and Retirement Funds for the Foundational Assay of Its DermTech Melanoma Test (DMT)
From DermTech, Inc.
Via Business Wire
DermTech Grants New CEO Bret Christensen Inducement Award Under NASDAQ Listing Rule 5635(c)(4)
From DermTech, Inc.
Via Business Wire
DermTech Appoints Bret Christensen as New President and CEO
From DermTech, Inc.
Via Business Wire
Nasdaq Surges Over 2%; Fluor Posts Downbeat Earnings
U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining over 250 points on Friday. The Dow traded up 1.55% to 33,642.02 while the NASDAQ rose 2.21% to 12,231.41. The S&P... 
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Why Atlassian Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Gainers 
Via Benzinga
Crude Oil Rises Sharply; Johnson Controls Earnings Beat Views
U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining over 200 points on Friday. The Dow traded up 1.23% to 33,534.02 while the NASDAQ rose 1.76% to 12,176.68. The S&P... 
Via Benzinga
Dow Jumps 400 Points; US Economy Adds 253,000 Jobs In April
U.S. stocks traded higher this morning, with the Dow Jones gaining over 400 points on Friday. Following the market opening Friday, the Dow traded up 1.26% to 33,544.63 while the NASDAQ rose 1.33% to... 
Via Benzinga
DermTech Reports First-Quarter 2023 Financial Results
From DermTech, Inc.
Via Business Wire
New Survey Data Reveals Nearly 75% of Consumers Have Not Had a Full Skin Exam Within the Past 12 Months
From DermTech, Inc.
Via Business Wire
DermTech Announces Contract With New York Health Plan for the Foundational Assay of Its DermTech Melanoma Test (DMT)
From DermTech, Inc.
Via Business Wire
DermTech, Inc. (NASDAQ:DMTK) Investor Notice: Investigation over Possible Violations of Securities Laws
San Diego, CA -- (SBWIRE) -- 04/19/2023 -- DermTech, Inc. is under investigation over potential securities laws violations in connection with certain financial statements. 
Via SBWire
< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.